Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,190 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05777330Recruiting
Monitoring blood sugar swings to predict type 1 diabetes
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
Liège, LiègeAges 5–39 - NCT05752292Enrolling by invitation
Pregnant with gestational diabetes: share risk info to help
This study is testing how to share risk information during pregnancy in a way that helps patients feel more informed and empowered. It includes people currently pregnant with gestational diabetes and will ask about your preferences and understanding.
Pleasanton, CaliforniaAges 18 years+ - NCT07427251RecruitingPhase 4
Study to avoid low blood sugar after meals
This trial tests if a quick-acting glucagon nasal spray can prevent low blood sugar after meals in people with type 1 diabetes who use an automated insulin pump. If you count carbs and use NovoRapid or Fiasp insulin, this could help you avoid post-meal lows.
HerlevAges 18 years+ - NCT07598708RecruitingPhase 2/Phase 3
Cleminorexton for Narcolepsy: A New Treatment Study
This study tests whether a new medication called cleminorexton helps people with narcolepsy (a condition causing severe daytime sleepiness) sleep better and feel more alert. You would take this medication instead of your current narcolepsy drugs for several months to see if it works.
Colorado Springs, ColoradoAges 18–70 - NCT07654374RecruitingPhase 3
Study of a new pill for weight loss and diabetes
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
Birmingham, AlabamaAges 18–79 - NCT06767683RecruitingPhase 2/Phase 3
Long-term study of ALKS 2680 for narcolepsy and idiopathic hypersomnia
This study is for people with narcolepsy or idiopathic hypersomnia who have already taken part in an earlier ALKS 2680 study. It aims to see how well the medication works and how safe it is when taken for a longer time.
Cullman, AlabamaAges 18–70 - NCT04931537Recruiting
Testing early kidney marker tests for people with diabetes
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
HangzhouAges 18–80 - NCT05390892RecruitingPhase 4
Preventing kidney and heart damage in type 2 diabetes
This study tests whether diabetes medicines can help prevent worsening heart and kidney problems in people with type 2 diabetes. You’ll be assigned by chance to one of these medicine types, and your other care will be adjusted for safety.
Huntsville, AlabamaAges 40–80 - NCT03059069RecruitingPhase 4
Gliatamin for low mood in adults with type 2 diabetes
This trial tests whether gliatamin (choline alphoscerate) can improve depressive mood in people with type 2 diabetes. You may be eligible if your diabetes is fairly controlled and your depression symptoms are in a mild-to-moderate range.
SeoulAges 50 years+ - NCT05015283Recruiting
Gastric bypass type surgery to help type 2 diabetes go into remission
This study compares two kinds of weight-loss surgeries to see which helps people with type 2 diabetes reach diabetes remission more safely. It may help if your diabetes is not well controlled and your care team recommends one of these operations.
Beijing, Beijing MunicipalityAges 18–65 - NCT07019012RecruitingPhase 4
Testing a new every-2-week pill for type 2 diabetes
This study tests a new once-every-2-weeks pill (cofrogliptin) added to your current diabetes medications (metformin and dapagliflozin) compared to a daily pill (linagliptin). It may help improve blood sugar control with fewer daily pills.
Wuhan, HubeiAges 18 years+ - NCT07319286Enrolling by invitationPhase 1/Phase 2
GLP-1 drug for period problems in teens with type 1 diabetes
This trial tests whether a GLP-1 receptor agonist can help improve irregular periods in teenage girls with type 1 diabetes. It's for girls aged 12 to 18 who have had their period for at least 2 years, use a continuous glucose monitor, and have higher blood sugar levels (HbA1c of 7% or more).
Cairo, Cairo GovernorateAges 12–18 - NCT06989697RecruitingPhase 3
Cilostazol and ginkgo for memory in older adults with diabetes
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
Seongnam-siAges 60 years+ - NCT07441655Recruiting
Family program for healthy habits and preventing diabetes
This study helps Black parents with prediabetes and their children make healthy lifestyle changes together to prevent diabetes. It lasts about 20 months and involves physical activity and nutrition support.
Albany, GeorgiaAges 18 years+ - NCT06296485Recruiting
Safer Aging with Diabetes Monitoring
This study tests a way to help older adults with type 2 diabetes who use insulin avoid dangerously low blood sugar. You would use a continuous glucose monitor and get support via email or internet to stay safe.
Fremont, CaliforniaAges 75 years+ - NCT07428746RecruitingPhase 3
GLP-1 drug for bone health in older women with diabetes
This study tests whether a diabetes medication called a GLP-1 receptor agonist can help improve bone and muscle health in older women with type 2 diabetes who are at risk for osteoporosis. It aims to see if the drug can strengthen bones and prevent falls.
Atlanta, GeorgiaAges 65 years+ - NCT07743021Recruiting
Blood sample study for better health screening
This study collects blood samples and health information over time to improve early detection of diseases. It may help researchers find ways to prevent serious conditions.
BalatonfüredAges 40 years+ - NCT07032844Recruiting
Better diabetes care for people with physical disabilities using telehealth
This trial tests if telehealth support through your primary care doctor can help you manage type 2 diabetes and other health conditions. It focuses on people who have a physical disability and need help controlling their blood sugar.
Birmingham, AlabamaAges 18–89 - NCT06630182Recruiting
Does personality affect diabetic foot wound healing?
This study looks at how your feelings and personality might affect the healing of a diabetic foot wound. Researchers will ask you to complete questionnaires about your emotional state to see if there is a link to wound recovery.
DijonAges 18–18 - NCT07722910Recruiting
Iris blood flow in diabetic neovascular glaucoma
This study uses a special camera (OCTA) to look at blood flow in the iris of people with or without type 2 diabetes and diabetic neovascular glaucoma. The goal is to understand how blood flow changes in this eye condition.
Jinan, ShandongAges 18 years+ - NCT06497595Recruiting
Lifestyle program to prevent muscle loss in older adults with diabetes on semaglutide
This trial tests whether a lifestyle program (diet and exercise) can help prevent muscle loss in people 65 and older with type 2 diabetes and obesity who are taking semaglutide. It may help you keep your strength and independence while losing weight.
Jerusalem, IsraelAges 65 years+ - NCT07053319RecruitingPhase 1
Study of diabetes drugs and ketones
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
San Antonio, TexasAges 30–75 - NCT07272837Recruiting
How semaglutide affects heart and muscle mass
This study looks at how semaglutide (Ozempic or Wegovy) changes heart muscle and body muscle. It may help people with type 2 diabetes or those taking the drug for weight loss understand if their heart is affected.
Edmonton, AlbertaAges 18–80 - NCT06784375Recruiting
Personalized diabetes education with a continuous glucose monitor
This study tests if a personalized education program, supported by continuous glucose monitor (CGM) wear, can help adults with type 2 diabetes improve their blood sugar control. Participants will receive extra training and a CGM device to see how food, activity, and medications affect their glucose levels in real time.
Minneapolis, MinnesotaAges 18 years+
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,190 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.